The vision ofthe Charles Drew University of Medicine and Science (CDU) Research Enterprise is to be a leading national resource for conducting clinical and translational research that produces high-quality, costeffective and culturally relevant solutions that improve health and wellness in minority and poor populations. By promoting strategies that create synergy in research teams and between investigators and the community, CDU will create novel best practice solutions to transform the health of underserved communities that can be used as innovative models throughout the nation and the world. CDU submits this application in response to the NIH Program Announcement (PAR-08-262) to implement the consolidation of the Comprehensive Center for Health Disparities (CCHD) and Clinical Research Center (CRC) into Accelerating excellence In Science (AXIS). AXIS will be the catalyst to implement the CDU research strategic plan and will become the integrated "home" for clinical and translational research. AXIS will house experienced and dedicated leadership;a myriad of clinical and translational, community, training, and technology resources;and excellent research consultation services. As its cornerstone, AXIS wi|l have multiand interdisciplinary collaborations between CDU investigators and community partners. These team science activities will be supported by CDU biomedical informatics resources, and other innovative research tools and information technologies (detailed below) aligned in an integrated manner to create a vibrant center for clinical and translational science. The overall purpose of AXIS is to better position CDU for conducting clinical and translational research, especially research that is focused on health disparities. The goals are to: Goal 1: Transform the CDU research enterprise from traditional basic and clinical research domains into a highly integrated clinical and translational research environment by reorganizing research administration, centralizing and enhancing physical and intellectual resources, and promoting participation in the RCMI Translational Research Network (RTRN) and Clinical and Translational Science Institutes (CTSI). Goal 2: Develop a unique model for community, multi-disciplinary, and/or multi-institutional partnerships that ensures that clinical and translational research yields high-quality, cost-effective health outcomes Goal 3: Implement innovative translational research training and career development activities at CDU and in partnership with RTRN that recognize that the interdependence of basic science, clinical discovery, and patient-oriented research will accelerate improved patient outcomes.

Agency
National Institute of Health (NIH)
Institute
National Institute on Minority Health and Health Disparities (NIMHD)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
8U54MD007598-04
Application #
8319602
Study Section
Special Emphasis Panel (ZRR1-RI-8 (01))
Program Officer
Mcclure, Shelia A
Project Start
2009-09-28
Project End
2014-06-30
Budget Start
2012-07-19
Budget End
2013-06-30
Support Year
4
Fiscal Year
2012
Total Cost
$3,380,388
Indirect Cost
$1,186,804
Name
Charles R. Drew University of Medicine & Science
Department
None
Type
Other Domestic Higher Education
DUNS #
785877408
City
Los Angeles
State
CA
Country
United States
Zip Code
90059
Wang, Piwen; Phan, Tien; Gordon, David et al. (2015) Arctigenin in combination with quercetin synergistically enhances the antiproliferative effect in prostate cancer cells. Mol Nutr Food Res 59:250-61
Garcia, Leah A; Hlaing, Su M; Gutierrez, Richard A et al. (2014) Sildenafil attenuates inflammation and oxidative stress in pelvic ganglia neurons after bilateral cavernosal nerve damage. Int J Mol Sci 15:17204-20
Davidson, Mayer B (2014) Insulin analogs--is there a compelling case to use them? No! Diabetes Care 37:1771-4
Davidson, Mayer B; Duran, Petra; Lee, Martin L (2014) Community screening for pre-diabetes and diabetes using HbA1c levels in high-risk African Americans and Latinos. Ethn Dis 24:195-9
Davidson, Mayer B; Pan, Deyu (2014) Epidemiological ramifications of diagnosing diabetes with HbA1c levels. J Diabetes Complications 28:464-9
Wu, Yanyuan; Kim, Juri; Elshimali, Yayha et al. (2014) Activation of Akt1 accelerates carcinogen-induced tumorigenesis in mammary gland of virgin and post-lactating transgenic mice. BMC Cancer 14:266
Tan, Gemma; Elefanty, Andrew G; Stanley, Edouard G (2014) *-cell regeneration and differentiation: how close are we to the 'holy grail'? J Mol Endocrinol 53:R119-29
Del Pino, Homero E; Moore, Mignon R; McCuller, William J et al. (2014) Negotiating Emotional Support: Sober Gay Latinos and their Families. J Gay Lesbian Soc Serv 26:222-243
Davidson, Mayer B (2014) Self-mixed/split insulin regimen: a serious omission in the ADA/EASD position statement. Diabetes Care 37:3-4
Bazargan-Hejazi, Shahrzad; Kim, Eunjin; Lin, Johnny et al. (2014) Risk factors associated with different types of intimate partner violence (IPV): an emergency department study. J Emerg Med 47:710-20

Showing the most recent 10 out of 53 publications